SARS-CoV-2

A single-shot vaccine for COVID-19

Some human testing begun, with phase 3 trials possible as soon as September.

Scientists uncover SARS-CoV-2-specific T cell immunity in recovered COVID-19 and SARS patients

Singapore scientists uncover SARS-CoV-2-specific T cell immunity in recovered COVID-19 and SARS patients, and in uninfected individuals.

Researchers develop novel COVID-19 swabs to address global and local shortage

More than 40 million of the new NUS-designed, clinically-tested nasopharyngeal swabs are being produced in Singapore.

Remdesivir shows early promise in the fight against COVID-19

Remdesivir potently inhibited SARS-CoV-2, the virus which causes COVID-19.

Neurological complications of COVID-19 can include delirium, rare brain inflammation and stroke

Preliminary clinical data indicate that COVID-19 infection is associated with neurological and neuropsychiatric illness. Now a new study by the UCL and...

A new robotic system that powerfully disinfects large surfaces in half an hour

A team from MIT's Computer Science and Artificial Intelligence Laboratory (CSAIL), in collaboration with Ava Robotics and the Greater Boston Food Bank...

COVID-19 might emerge from shuffling and selection of viral genes across different species

Understanding the origins of SARS-CoV-2 is critical for deterring future zoonosis, discovering new drugs, and developing a vaccine. According...

How SARS-CoV-2 interact with a host cell?

Using single-cell RNA sequencing, scientists at the Yale School of Medicine (YSM) are learning single-cell RNA sequencing of infected human bronchial epithelial...

First human trial of COVID-19 vaccine found to be safe and effective

The first COVID-19 vaccine called adenovirus type-5 (Ad5) vectored COVID-19 vaccine that underwent a phase 1 clinical trial found to be safe,...

Mouthwash can halt the transmission of COVID-19

SARS-CoV-2 is an enveloped virus, characterized by an outer lipid membrane derived from the host cell from which it buds.